AMDA - Amedica Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
+0.0202 (+7.48%)
At close: 3:54PM EDT
Stock chart is not supported by your current browser
Previous Close0.2698
Bid0.00 x 800
Ask0.00 x 900
Day's Range0.2647 - 0.3163
52 Week Range0.1820 - 4.1200
Avg. Volume1,729,624
Market Cap3.442M
Beta (3Y Monthly)-1.89
PE Ratio (TTM)N/A
EPS (TTM)-5.25
Earnings DateMar 17, 2017 - Mar 20, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.35
Trade prices are not sourced from all markets
  • GlobeNewswirelast month


    Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced that it has changed its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and robust pipeline of silicon nitride based products in various biomedical applications. The company expects to change its trading symbol on the NASDAQ Capital Market to “SINT” in approximately 10 days.

  • GlobeNewswire2 months ago


    Amedica Corporation (AMDA) today announced that it has completed the previously-announced sale of its spine business to CTL Medical, a Dallas, TX-based privately held medical device manufacturer, on October 1, 2018, all as more fully described below. As previously announced, Amedica and CTL Medical entered in an asset purchase agreement, dated September 5, 2018, whereby CTL Medical agreed to acquire all of Amedica’s commercial spine business for total consideration of up to $10 million. As a result of the closing, CTL Medical is now the exclusive owner of Amedica’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies.

  • ACCESSWIRE3 months ago

    Amedica Agrees to Sell its Commercial Spine Products Business, Analyst Coverage

    NEW YORK, NY / ACCESSWIRE / September 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • ACCESSWIRE5 months ago

    Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks revisits the Medical Appliances and Equipment space, which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Under evaluation this morning are these four stocks: EDAP TMS S.A. (NASDAQ: EDAP), PAVmed Inc. (NASDAQ: PAVM), Amedica Corp. (NASDAQ: AMDA), and Avinger Inc. (NASDAQ: AVGR).

  • ACCESSWIRE6 months ago

    Initiating Free Research Reports on Avinger and Three Other Medical Equipment Equities

    Pre-market today, scans the following Medical Appliances and Equipment stocks: Amedica Corp. (NASDAQ: AMDA), Avinger Inc. (NASDAQ: AVGR), AxoGen Inc. (NASDAQ: AXGN), and Corindus Vascular Robotics Inc. (NYSE AMER: CVRS).

  • How Financially Strong Is Amedica Corporation (NASDAQ:AMDA)?
    Simply Wall St.6 months ago

    How Financially Strong Is Amedica Corporation (NASDAQ:AMDA)?

    Amedica Corporation (NASDAQ:AMDA) is a small-cap stock with a market capitalization of US$4.80M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they endRead More...

  • ACCESSWIRE7 months ago

    Abbott Labs and Three Additional Medical Equipment Stocks on Our Research Desk’s Radar

    On Wednesday, May 23, 2018, US markets saw broad based gains with six out of nine sectors finishing the trading sessions in green. This Thursday morning, looks at the performance of these four Medical Appliances & Equipment stocks: Abbott Laboratories (NYSE: ABT), ABIOMED Inc. (NASDAQ: ABMD), Align Technology Inc. (NASDAQ: ALGN), and Amedica Corp. (NASDAQ: AMDA).

  • ACCESSWIRE7 months ago

    Today’s Research Reports on Stocks to Watch: Amedica Corporation and Aralez Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / May 9, 2018 / Aralez Pharmaceutical shares sunk on Tuesday after reporting first quarter results, despite a third consecutive quarter of positive adjusted EBITDA. Shares of Amedica had a better day yesterday exploding to a close of over 180% after providing Wall Street with some updates on its clinical study activities. The innovative biomaterial company saw its shares explode after providing an update on its clinical study activities including a Single Center Retrospective Comparative Study and a Multi-Center Retrospective Study.

  • What Should You Know About Amedica Corporation’s (NASDAQ:AMDA) Growth?
    Simply Wall St.8 months ago

    What Should You Know About Amedica Corporation’s (NASDAQ:AMDA) Growth?

    The latest earnings release Amedica Corporation’s (NASDAQ:AMDA) announced in December 2017 confirmed company earnings became less negative compared to the previous year’s level – great news for investors Below, I’veRead More...

  • Does Amedica Corporation’s (NASDAQ:AMDA) Latest Financial Perfomance Look Strong?
    Simply Wall St.9 months ago

    Does Amedica Corporation’s (NASDAQ:AMDA) Latest Financial Perfomance Look Strong?

    Assessing Amedica Corporation’s (NASDAQ:AMDA) past track record of performance is an insightful exercise for investors. It allows us to reflect on whether or not the company has met or exceedRead More...